160 related articles for article (PubMed ID: 23537782)
1. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Sharma C; Wankhede S; Muralidhar S; Prakash A; Singh PK; Kathuria S; Kumar DA; Khan N; Randhawa HS; Meis JF; Chowdhary A
Diagn Microbiol Infect Dis; 2013 May; 76(1):46-50. PubMed ID: 23537782
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.
Tay ST; Lotfalikhani A; Sabet NS; Ponnampalavanar S; Sulaiman S; Na SL; Ng KP
Mycopathologia; 2014 Oct; 178(3-4):307-14. PubMed ID: 25022264
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis.
Li J; Shan Y; Fan S; Liu X
Mycopathologia; 2014 Oct; 178(3-4):279-83. PubMed ID: 25118875
[TBL] [Abstract][Full Text] [Related]
6. [First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula].
López-Soria LM; Bereciartua E; Santamaría M; Soria LM; Hernández-Almaraz JL; Mularoni A; Nieto J; Montejo M
Rev Iberoam Micol; 2013 Jan; 30(1):69-71. PubMed ID: 22982698
[TBL] [Abstract][Full Text] [Related]
7. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
[TBL] [Abstract][Full Text] [Related]
8. First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen.
Chowdhary A; Randhawa HS; Khan ZU; Ahmad S; Juneja S; Sharma B; Roy P; Sundar G; Joseph L
Med Mycol; 2010 Mar; 48(2):416-20. PubMed ID: 19626545
[TBL] [Abstract][Full Text] [Related]
9. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
12. Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India.
Sharma C; Muralidhar S; Xu J; Meis JF; Chowdhary A
Mycoses; 2014 Sep; 57(9):544-52. PubMed ID: 24697839
[TBL] [Abstract][Full Text] [Related]
13. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.
Borman AM; Petch R; Linton CJ; Palmer MD; Bridge PD; Johnson EM
J Clin Microbiol; 2008 Mar; 46(3):933-8. PubMed ID: 18199788
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Antifungal Susceptibility of Candida nivariensis from Vulvovaginal Candidiasis.
Shi Y; Zhu Y; Fan S; Vitagliano A; Liu X; Liao Y; Liang Y; Vitale SG
Gynecol Obstet Invest; 2020; 85(1):88-93. PubMed ID: 31694024
[TBL] [Abstract][Full Text] [Related]
16. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
Asticcioli S; Sacco L; Daturi R; Matti C; Nucleo E; Zara F; Pagani L
New Microbiol; 2009 Apr; 32(2):199-204. PubMed ID: 19579700
[TBL] [Abstract][Full Text] [Related]
17. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
18. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.
Bishop JA; Chase N; Magill SS; Kurtzman CP; Fiandaca MJ; Merz WG
J Clin Microbiol; 2008 Feb; 46(2):443-6. PubMed ID: 18077641
[TBL] [Abstract][Full Text] [Related]
19. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
